Dimensional Fund Advisors »

Lenz Therapeutics shares owned by Dimensional Fund Advisors

Quarter-by-quarter ownership of Lenz Therapeutics shares owned by Dimensional Fund Advisors from 13F filings

Historical chart of Dimensional Fund Advisors investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Dimensional Fund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Dimensional Fund Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $526k 24k 22.33

More positions owned by Dimensional Fund Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Chevron Corporation (CVX)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)

View all positions for Dimensional Fund Advisors

Top funds holding Lenz Therapeutics

RA Capital Management
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
Point72 Asset Management
Tang Capital Management
BlackRock
Vanguard Group
Alyeska Investment Group
Jennison Associates
Board of Trustees of The Leland Stanford Junior University
Geode Capital Management
Ikarian Capital
Prosight Management
BML Capital Management

View all funds holding Lenz Therapeutics